Latest News about LLY
Recent news which mentions LLY
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Is It Time to Sell Eli Lilly and Pfizer Stocks?
November 20, 2024
From Motley Fool
From Benzinga
From Benzinga
The Smartest Megacap Growth ETF to Buy With $500 Right Now
November 19, 2024
From Motley Fool
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
November 18, 2024
From Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
November 18, 2024
From Motley Fool
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
November 17, 2024
Tickers
LLY
From Motley Fool
From Benzinga
Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now
November 17, 2024
From Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
November 16, 2024
From Motley Fool
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
From Benzinga
From Motley Fool
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
From Motley Fool
2 Top Growth Stocks to Buy on the Dip
November 14, 2024
From Motley Fool
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
November 14, 2024
From Motley Fool
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
November 13, 2024
From Motley Fool
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
November 13, 2024
From Benzinga
2 S&P 500 Dividend Stocks That Could Soar 30% or More, According to a Pair of Wall Street Analysts
November 13, 2024
From Motley Fool
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
November 12, 2024
From Benzinga
Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal
November 12, 2024
Tickers
LLY
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.